Natera
A company developing tests for pre-implantation genetic diagnosis for IVF and non-invasive prenatal test
9
Funding Rounds
$404.1m
Money raised
Overview
A company developing tests for pre-implantation genetic diagnosis for IVF and non-invasive prenatal test
-
Website:
- Business model: B2B
- Headquarters: San Carlos, California
- Social accounts:
Funding series
Funding Series Analysis
The company Natera has raised a total of $20m in funding over 9 rounds.
Key Insights:
- Natera funding round, January 2012: $20m
- Natera Series A round, December 2008: $4m
- Natera Series F round, April 2015: $55.5m
- Natera Series E round, May 2013: $54.6m
- Natera Post-IPO Equity, April 2020: $250m
- Natera Grant (money), April 2011: $2m
- Natera Series C round, November 2010: $12m
- Natera Series B round, January 2009: $6m
Natera funding round, January 2012
$20m
Natera Series A round, December 2008
$4m
Natera Series F round, April 2015
$55.5m
Natera Series E round, May 2013
$54.6m
Natera Post-IPO Equity, April 2020
$250m
Natera Grant (money), April 2011
$2m
Natera Series C round, November 2010
$12m
Natera Series B round, January 2009
$6m
Industries
Natera is active in the following industries: